Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Xiaoshuan enteric-coated capsules
- Development stage
- Unknown
- Lead developer
- Sanmenxia Sinoway Pharmaceutical
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Xiaoshuan enteric-coated capsule (XSECC) is a compound Traditional Chinese Medicine (TCM) preparation derived from the classical formula Buyang Huanwu Decoction (BYHWD). It is approved by the China National Medical Products Administration (NMPA) for the management of stroke and cerebral infarction, specifically to promote brain remodeling and plasticity. The formulation is manufactured by Sanmenxia Sinoway Pharmaceutical. It is currently being investigated in Phase 4 clinical trials for the treatment of fatigue syndrome following cardiovascular and cerebrovascular events, such as myocardial infarction and coronary heart disease treated with percutaneous coronary intervention (PCI). Its mechanism involves neurovascular modulation, including the regulation of Vascular Endothelial Growth Factor (VEGF) and Brain-Derived Neurotrophic Factor (BDNF).
- Brand names
- Xiaoshuan
- Other names
- Xiaoshuan enteric-coated capsuleXSECCXiaoshuan Changrong Jiaonang
02
Targets
Beyond the preview
Go deeper on Xiaoshuan enteric-coated capsules.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Xiaoshuan enteric-coated capsules.